These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 7792821)
61. Studies on the mechanism of mineralocorticoid-induced blood pressure increase in man. Distler A; Philipp T; Lüth B; Wucherer G Clin Sci (Lond); 1979 Dec; 57 Suppl 5():303s-305s. PubMed ID: 396080 [TBL] [Abstract][Full Text] [Related]
62. High blood pressure management: potential benefits of I1 agents. Esler M J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906 [TBL] [Abstract][Full Text] [Related]
63. Late-night salivary cortisol as a screening test for Cushing's syndrome. Raff H; Raff JL; Findling JW J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931 [TBL] [Abstract][Full Text] [Related]
64. Effects of prazosin on hemodynamics and sympatho-adrenal activity in hypertensive patients. Eklund B; Hjemdahl P; Seideman P; Atterhög JH J Cardiovasc Pharmacol; 1983; 5(3):384-91. PubMed ID: 6191136 [TBL] [Abstract][Full Text] [Related]
65. The sympathetic nervous system in essential hypertension. Tuck ML Am Heart J; 1986 Oct; 112(4):877-86. PubMed ID: 3532745 [TBL] [Abstract][Full Text] [Related]
67. The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome. Barbot M; Ceccato F; Scaroni C Front Endocrinol (Lausanne); 2019; 10():321. PubMed ID: 31164868 [TBL] [Abstract][Full Text] [Related]
68. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777 [TBL] [Abstract][Full Text] [Related]
69. Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome. Papanicolaou DA; Mullen N; Kyrou I; Nieman LK J Clin Endocrinol Metab; 2002 Oct; 87(10):4515-21. PubMed ID: 12364428 [TBL] [Abstract][Full Text] [Related]
71. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension. Walker BR; Stewart PM; Shackleton CH; Padfield PL; Edwards CR Clin Endocrinol (Oxf); 1993 Aug; 39(2):221-7. PubMed ID: 8370136 [TBL] [Abstract][Full Text] [Related]
72. Essential hypertension: neural considerations. Dustan HP Med Clin North Am; 1987 Sep; 71(5):897-905. PubMed ID: 3306209 [TBL] [Abstract][Full Text] [Related]
73. Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs. Noll G; Wenzel RR; Binggeli C; Corti C; Lüscher TF Eur Heart J; 1998 Jun; 19 Suppl F():F32-8. PubMed ID: 9651733 [TBL] [Abstract][Full Text] [Related]
74. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity. Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315 [TBL] [Abstract][Full Text] [Related]
75. Impaired cortisol binding to glucocorticoid receptors in hypertensive patients. Mulatero P; Panarelli M; Schiavone D; Rossi A; Mengozzi G; Kenyon CJ; Chiandussi L; Veglio F Hypertension; 1997 Nov; 30(5):1274-8. PubMed ID: 9369287 [TBL] [Abstract][Full Text] [Related]
76. Systemic and regional hemodynamics in patients with salt-sensitive hypertension. Fujita T; Ando K; Ogata E Hypertension; 1990 Sep; 16(3):235-44. PubMed ID: 2394483 [TBL] [Abstract][Full Text] [Related]
77. Sodium and obesity in the pathogenesis of hypertension. Reisin E Am J Hypertens; 1990 Feb; 3(2):164-7. PubMed ID: 2155002 [TBL] [Abstract][Full Text] [Related]
78. Baroreflex buffering and susceptibility to vasoactive drugs. Jordan J; Tank J; Shannon JR; Diedrich A; Lipp A; Schröder C; Arnold G; Sharma AM; Biaggioni I; Robertson D; Luft FC Circulation; 2002 Mar; 105(12):1459-64. PubMed ID: 11914255 [TBL] [Abstract][Full Text] [Related]